Trial · NCT03498521
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression Free Survival (PFS) as Assessed by the Investigator According to Response Evaluation Criteria In Solid Tumors v1.1 (RECIST v1.1) | Molecularly-Guided Therapy (MGT) Category 1 | 6.14 | 95% Confidence Interval 4.70 to 6.47 | Months | |
| Progression Free Survival (PFS) as Assessed by the Investigator According to Response Evaluation Criteria In Solid Tumors v1.1 (RECIST v1.1) | Chemotherapy Category 1 | 4.40 | 95% Confidence Interval 4.17 to 6.37 | Months | |
| Overall Survival (OS) | Molecularly-Guided Therapy MGT) Category 1 | 15.18 | 95% Confidence Interval 13.90 to 18.43 | Months | |
| Overall Survival (OS) | Chemotherapy Category 1 | 12.78 | 95% Confidence Interval 9.86 to 15.38 | Months | |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Complete response (CR) | 4.9 | 95% Confidence Interval 2.83 to 7.85 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Complete response (CR) | 3.6 | 95% Confidence Interval 1.00 to 9.05 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Partial response (PR) | 12.9 | 95% Confidence Interval 9.45 to 17.01 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Partial response (PR) | 4.5 | 95% Confidence Interval 1.49 to 10.29 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Stable disease (SD) | 44.5 | 95% Confidence Interval 39.00 to 50.06 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Stable disease (SD) | 49.1 | 95% Confidence Interval 39.43 to 58.80 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Non-CR/Non-PD | 7.1 | 95% Confidence Interval 4.52 to 10.40 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Non-CR/Non-PD | 6.4 | 95% Confidence Interval 2.60 to 12.67 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Not Applicable (NA) | 2.5 | 95% Confidence Interval 1.07 to 4.78 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Not Applicable (NA) | 2.7 | 95% Confidence Interval 0.57 to 7.76 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Progressive disease (PD) | 17.8 | 95% Confidence Interval 13.80 to 22.38 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Progressive disease (PD) | 21.8 | 95% Confidence Interval 14.51 to 30.70 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Not evaluable participants | 0.6 | 95% Confidence Interval 0.07 to 2.20 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Not evaluable participants | 0 | 95% Confidence Interval 0.00 to 3.30 | Percentage of participants |
| Objective Response Rate (ORR) | Molecularly-Guided Therapy MGT) Category 1 | Missing participants | 9.8 | 95% Confidence Interval 6.81 to 13.57 | Percentage of participants |
| Objective Response Rate (ORR) | Chemotherapy Category 1 | Missing participants | 11.8 | 95% Confidence Interval 6.45 to 19.36 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03498521/results